14-3-3γ 3 mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage

EMBO Journal

Volumn 29, Issue 16, 2010, Pages 2802-2812

  Kasahara, Kousuke ^a   Goto, Hidemasa ^a,b   Enomoto, Masato ^a,b   Tomono, Yasuko ^c   Kiyono, Tohru ^d   Inagaki, Masaki ^a,b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Shigei Medical Research Institute   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

14 3 3; Cdc25; Chk1; DNA damage checkpoint; phosphorylation

Indexed keywords

ALANINE; ATR PROTEIN; CDC25A PROTEIN; CELL NUCLEUS DNA; CHECKPOINT KINASE 1; PROTEIN; PROTEIN 14 3 3GAMMA; PROTEIN TYROSINE PHOSPHATASE; SERINE; UNCLASSIFIED DRUG; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; BTRC PROTEIN, HUMAN; PROTEIN 14 3 3; PROTEIN KINASE;

ARTICLE; CATALYSIS; CELL NUCLEUS; DNA DAMAGE; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; ULTRAVIOLET IRRADIATION; CELL CYCLE; HELA CELL; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING;

MAMMALIA; SCHIZOSACCHAROMYCETACEAE;

14-3-3 PROTEINS; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; CDC25 PHOSPHATASES; CELL CYCLE; CELL NUCLEUS; DNA DAMAGE; HELA CELLS; HUMANS; MITOSIS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; SERINE;

EID: 77955849465     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2010.157     Document Type: Article

References (42)

1. Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421-429
2. Boutros R, Lobjois V, Ducommun B (2007) CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 7: 495-507
3. Busino L, Chiesa M, Draetta GF, Donzelli M (2004) Cdc25A phos-phatase: combinatorial phosphorylation, ubiquitylation and pro-teolysis. Oncogene 23: 2050-2056
4. Busino L, Donzelli M, Chiesa M, Guardavaccaro D, Ganoth D, Dorrello NV, Hershko A, Pagano M, Draetta GF (2003) Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 426: 87-91
5. Chen MS, Hurov J, White LS, Woodford-Thomas T, Piwnica-Worms H (2001) Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol Cell Biol 21: 3853-3861
6. Chen MS, Ryan CE, Piwnica-Worms H (2003) Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol 23: 7488-7497
7. Chen P, Luo C, Deng Y, Ryan K, Register J, Margosiak S, Tempczyk-Russell A, Nguyen B, Myers P, Lundgren K, Kan CC, O'Connor PM (2000) The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell 100: 681-692
8. Clarke CA, Clarke PR (2005) DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system. Biochem J 388: 705-712
9. Dunaway S, Liu HY, Walworth NC (2005) Interaction of 14-3-3 protein with Chk1 affects localization and checkpoint function. J Cell Sci 118: 39-50
10. Ferguson AM, White LS, Donovan PJ, Piwnica-Worms H (2005) Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol Cell Biol 25: 2853-2860
11. Ford JC, al-Khodairy F, Fotou E, Sheldrick KS, Griffiths DJ, Carr AM (1994) 14-3-3 protein homologs required for the DNA damage checkpoint in fission yeast. Science 265: 533-535
12. Furnari B, Rhind N, Russell P (1997) Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science 277: 1495-1497
13. Goto H, Inagaki M (2007) Production of a site-and phosphorylation state-specific antibody. Nat Protoc 2: 2574-2581
14. Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, Sakurai M, Okawa K, Iwamatsu A, Okigaki T, Takahashi T, Inagaki M (1999) Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem 274: 25543-25549
15. Ikegami Y, Goto H, Kiyono T, Enomoto M, Kasahara K, Tomono Y, Tozawa K, Morita A, Kohri K, Inagaki M (2008) Chk1 phosphor-ylation at Ser286 and Ser301 occurs with both stalled DNA replication and damage checkpoint stimulation. Biochem Biophys Res Commun 377: 1227-1231
16. Jackman MR, Pines JN (1997) Cyclins and the G2/M transition. Cancer Surv 29: 47-73
17. Jiang K, Pereira E, Maxfield M, Russell B, Goudelock DM, Sanchez Y (2003) Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345. J Biol Chem 278: 25207-25217
18. Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge SJ, Harper JW (2003) SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev 17: 3062-3074
19. Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432: 316-323
20. Katsuragi Y, Sagata N (2004) Regulation of Chk1 kinase by auto-inhibition and ATR-mediated phosphorylation. Mol Biol Cell 15: 1680-1689
21. Leung-Pineda V, Ryan CE, Piwnica-Worms H (2006) Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit. Mol Cell Biol 26: 7529-7538
22. Lincoln AJ, Wickramasinghe D, Stein P, Schultz RM, Palko ME, De Miguel MP, Tessarollo L, Donovan PJ (2002) Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation. Nat Genet 30: 446-449
23. Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H, Liddington R (1995) Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 376: 191-194
24. Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Bartek J, Lukas J (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science 288: 1425-1429
25. Melixetian M, Klein DK, Sorensen CS, Helin K (2009) NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint. Nat Cell Biol 11: 1247-1253
26. Mohammad DH, Yaffe MB (2009) 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response. DNA Repair (Amst) 8: 1009-1017
27. Neely KE, Piwnica-Worms H (2003) Cdc25A regulation: to destroy or not to destroy\is that the only question? Cell Cycle 2: 455-457
28. Peng CY, Graves PR, Ogg S, Thoma RS, Byrnes III MJ, Wu Z, Stephenson MT, Piwnica-Worms H (1998) C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ 9: 197-208
29. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277: 1501-1505
30. Pines J (1999) Cell cycle. Checkpoint on the nuclear frontier. Nature 397: 104-105
31. Puc J, Keniry M, Li HS, Pandita TK, Choudhury AD, Memeo L, Mansukhani M, Murty VV, Gaciong Z, Meek SE, Piwnica-Worms H, Hibshoosh H, Parsons R (2005) Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7: 193-204
32. Ray D, Kiyokawa H (2007) CDC25A levels determine the balance of proliferation and checkpoint response. Cell Cycle 6: 3039-3042
33. Ray D, Terao Y, Nimbalkar D, Hirai H, Osmundson EC, Zou X, Franks R, Christov K, Kiyokawa H (2007) Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumor-igenesis in mice. Cancer Res 67: 6605-6611
34. Russell P (1998) Checkpoints on the road to mitosis. Trends Biochem Sci 23: 399-402
35. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ (1997) Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277: 1497-1501
36. Schmitt E, Boutros R, Froment C, Monsarrat B, Ducommun B, Dozier C (2006) CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. J Cell Sci 119: 4269-4275
37. Sekimata M, Tsujimura K, Tanaka J, Takeuchi Y, Inagaki N, Inagaki M (1996) Detection of protein kinase activity specifically activated at metaphase-anaphase transition. J Cell Biol 132: 635-641
38. Smits VA, Reaper PM, Jackson SP (2006) Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr Biol 16: 150-159
39. Walker M, Black EJ, Oehler V, Gillespie DA, Scott MT (2009) Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity. Oncogene 28: 2314-2323
40. Zhao H, Piwnica-Worms H (2001) ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 21: 4129-4139
41. Zhou BB, Elledge SJ (2000) The DNA damage response: putting checkpoints in perspective. Nature 408: 433-439
42. Zou L, Elledge SJ (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300: 1542-1548